Question Title * 1. How well did the case study fulfil the following learning objectives?Upon completion of this educational activity, I am better able to: Strongly Agree Agree Neutral Disagree Strongly Disagree Understand how to diagnose and initially manage a child with ADA-SCID Understand how to diagnose and initially manage a child with ADA-SCID Strongly Agree Understand how to diagnose and initially manage a child with ADA-SCID Agree Understand how to diagnose and initially manage a child with ADA-SCID Neutral Understand how to diagnose and initially manage a child with ADA-SCID Disagree Understand how to diagnose and initially manage a child with ADA-SCID Strongly Disagree Describe the non-immunological features of the disorder Describe the non-immunological features of the disorder Strongly Agree Describe the non-immunological features of the disorder Agree Describe the non-immunological features of the disorder Neutral Describe the non-immunological features of the disorder Disagree Describe the non-immunological features of the disorder Strongly Disagree Question Title * 2. As a result of viewing this case study, will you make any measurable changes in your role? Yes Possibly, after additional training/information No, but the content affirms my current daily practice No, I am unable to implement the information Question Title * 3. Did you feel there was any bias (commercial or personal) evident within the education? Yes No Question Title * 4. How would you rate the overall quality of the case study?10=Excellent, 1=Poor 10 9 8 7 6 5 4 3 2 1 Question Title * 5. How did you find out about this case study? Email Twitter Colleague Banner advertisement Other (please specify) Question Title * 6. I would like to be kept informed of new educational content published by Springer Healthcare IME Please tick here Question Title * 7. Sign up for email alerts on ADA SCID here Yes No Question Title * 8. Country (please select) Afghanistan Albania Algeria Andorra Angola Antigua and Barbuda Argentina Armenia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bhutan Bolivia (Plurinational State of) Bosnia and Herzegovina Botswana Brazil Brunei Darussalam Bulgaria Burkina Faso Burundi Cabo Verde Cambodia Cameroon Canada Central African Republic Chad Chile China Colombia Comoros Congo Costa Rica Côte D'Ivoire Croatia Cuba Cyprus Czech Republic Democratic People's Republic of Korea Democratic Republic of the Congo Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland France Gabon Gambia Georgia Germany Ghana Greece Grenada Guatemala Guinea Guinea Bissau Guyana Haiti Holy See Honduras Hungary Iceland India Indonesia Iran (Islamic Republic of) Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati Kuwait Kyrgyzstan Lao People’s Democratic Republic Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Micronesia (Federated States of) Monaco Mongolia Montenegro Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Zealand Nicaragua Niger Nigeria Norway Oman Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Qatar Republic of Korea Republic of Moldova Romania Russian Federation Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Sudan Spain Sri Lanka State of Palestine Sudan Suriname Swaziland Sweden Switzerland Syrian Arab Republic Tajikistan Thailand The former Yugoslav Republic of Macedonia Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Tuvalu Uganda Ukraine United Arab Emirates United Kingdom of Great Britain and Northern Ireland United Republic of Tanzania United States of America Uruguay Uzbekistan Vanuatu Venezuela (Bolivarian Republic of) Vietnam Yemen Zambia Zimbabwe Question Title * 9. Any further questions, comments, or requests for future learning. Done